When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
New research is challenging one of medicine’s oldest assumptions: that cancer must be attacked to be cured. By treating ...
Cancer is a complex disease that evades the immune system through various mechanisms. The rapid proliferation of cells and their ability to resist therapy make cancer extremely aggressive. Solid ...
GRAND RAPIDS, Mich. — BAMF Health, a cancer treatment center in Grand Rapids, has launched a study to better understand a certain type of breast cancer. The non-invasive study seeks to find whether or ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel tumor ...
Researchers at the University of Texas at El Paso have developed a device they say can detect cancer markers in the blood with greater responsiveness than current diagnostic methods. The University of ...
Hologic is putting down about $310 million to acquire Endomagnetics, the developer of technologies for localizing tumors in breast cancer surgeries without using radioactive materials. Also known as ...
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic ...
No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...
The findings come out of the UH Cancer Center, Hawaiʻi’s only National Cancer Institute-designated cancer center. Based in Kakaʻako, the center directly employs more than 300 faculty and staff and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results